Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022

BUY
$0.27 - $3.6 $12,964 - $172,861
48,017 New
48,017 $14,000
Q2 2022

Aug 09, 2022

SELL
$0.38 - $0.55 $5,410 - $7,830
-14,237 Closed
0 $0
Q1 2022

May 17, 2022

BUY
$0.48 - $0.71 $6,833 - $10,108
14,237 New
14,237 $8,000
Q4 2021

Feb 17, 2022

SELL
$0.65 - $1.02 $12,177 - $19,108
-18,734 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$1.01 - $1.25 $98,869 - $122,363
-97,891 Reduced 83.94%
18,734 $20,000
Q2 2021

Sep 17, 2021

BUY
$1.08 - $2.14 $42,447 - $84,108
39,303 Added 50.83%
116,625 $146,000
Q1 2021

May 19, 2021

BUY
$1.3 - $2.35 $55,806 - $100,880
42,928 Added 124.81%
77,322 $107,000
Q4 2020

Feb 24, 2021

SELL
$0.8 - $2.16 $45,832 - $123,746
-57,290 Reduced 62.49%
34,394 $47,000
Q3 2020

Dec 11, 2020

BUY
$0.86 - $2.36 $78,848 - $216,374
91,684 New
91,684 $85,000
Q2 2020

Aug 07, 2020

SELL
$0.7 - $1.58 $19,838 - $44,778
-28,341 Closed
0 $0
Q4 2019

Feb 04, 2020

BUY
$0.39 - $2.05 $11,052 - $58,099
28,341 New
28,341 $14,000

About Cocrystal Pharma, Inc.


  • Ticker COCP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,122,420
  • Market Cap $14.3M
  • Description
  • Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...
More about COCP
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.